PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund
SK bioscience's board approval follows the Financial Services Commission's May 28 announcement selecting the company as a beneficiary of the KRW 300 billion (approximately USD 230 million) Korea Growth ...
2026-05-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
RingConn Gen 3 Smart Ring Officially Launches: Expanding Long-Term Health Awareness in Everyday Life
World's Leading Provider of Cutting-Edge Smart Ring Solutions ...
2026-05-29T    Computer/Electronics   Consumer Electronics   Health Care/Hospital 
Vantage Foundation Brings Smiles and Support to Residents of Victory Old Folks Home in Malaysia
VANTAGE FOUNDATION × TOUCHING LIVES CLUB ...
2026-05-29T    Entertainment   Health Care/Hospital 
Doctors at Omotesando Helene Clinic Publish New Study on Long-Term Safety Surveillance Following High-Dose Intravenous MSC Administration
Continuing clinical data analysis and academic publication in regenerative medicine and ATMP as the Tokyo clinical hub within Helene Bio Group ...
2026-05-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
HMS Vision Inc. and Wenzhou Medical University Announce the Expansion of Their Simulation-Based Training Center During Vision China 2026
TIANJIN, China , May 29, 2026 /PRNewswire/ -- HMS Vision Inc. announced this week at Vision China 2026 the expansion of the HelpMeSee Simulation-based Eye Surgery Training Program at the Eye Hospital ...
2026-05-29T    Computer/Electronics   Education   Health Care/Hospital   Medical Equipment 
Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
SAN FRANCISCO and NEW YORK, and SUZHOU, China , May 29, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (01801.HK) and Pfizer Inc. (NYSE: PFE), today announced the companies have entered into a strategic ...
2026-05-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Encouraging safety and preliminary efficacy analysis from the elacestrant and capivasertib Phase 1b regimen of the ELEVATE study will be presented. The efficacy data highlight how the combination ...
2026-05-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Sino Biological's Cell-Free Protein Synthesis Supports Tencent AI for Life Sciences Lab's Protein Design Study Published in Nature Communications
HOUSTON , May 28, 2026 /PRNewswire/ -- Sino Biological, Inc. (Shenzhen Stock Exchange: 301047.SZ) has announced that its gene synthesis and cell-free protein expression workflow was used in a recent ...
2026-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Haier Biomedical Achieves Double No. 1 Ranking in Euromonitor's Global Life Science Lab Equipment Report, Caps Three-Phase Global Expansion
QINGDAO, China , May 28, 2026 /PRNewswire/ -- Haier Biomedical (SHA: 688139) has been named the No. 1 Chinese brand in global life science laboratory equipment sales and No. 1 in overseas sales in ...
2026-05-28T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
NYSE Content Update: Hinge Health Shares Up 72% One Year from its IPO
NYSE issues a pre-market daily advisory direct from the trading floor. ...
2026-05-28T    Banking/Financial Service   Computer/Electronics   Health Care/Hospital 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.